Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Adicionar filtros








Intervalo de ano
1.
Braz. j. med. biol. res ; 34(4): 501-8, Apr. 2001. tab
Artigo em Inglês | LILACS | ID: lil-282615

RESUMO

The correlation between dietary trans fatty acids and neoplasia was examined in the present study. Walker 256 tumor-bearing and control rats were fed a trans monounsaturated fatty acid (MUFA)-rich diet for 8 weeks and the incorporation of trans fatty acids by tumor tissue was examined. Also, the effect of tumor growth on trans fatty acid composition of plasma and liver, and the content of thiobarbituric acid-reactive substances (TBARS) was determined. Walker 256 tumor cells presented both trans and cis MUFAs given in the diet. The equivalent diet proportions were 0.66 for trans and 1.14 for cis. Taking into consideration the proportion of trans MUFAs in plasma (11.47 percent), the tumor incorporated these fatty acids in a more efficient manner (18.27 percent) than the liver (9.34 percent). Therefore, the dietary trans fatty acids present in the diet are actively incorporated by the tumor. Tumor growth itself caused marked changes in the proportion of polyunsaturated fatty acids in the plasma and liver but provoked only slight modifications in both trans and cis MUFAs. Tumor growth also reduced the unsaturation index in both plasma and liver, from 97.79 to 86.83 and from 77.51 to 69.64, respectively. This effect was partially related to an increase in the occurrence of the lipid oxidation/peroxidation process of TBARS content which was increased in both plasma (from 0.428 to 0.505) and liver (from 9.425 to 127.792) due to tumor growth


Assuntos
Animais , Masculino , Ratos , Carcinoma 256 de Walker/metabolismo , Gorduras Insaturadas na Dieta/metabolismo , Ácidos Graxos Monoinsaturados/metabolismo , Neoplasias Mamárias Experimentais/metabolismo , Gorduras na Dieta/efeitos adversos , Ácidos Graxos Monoinsaturados/análise , Ácidos Graxos Monoinsaturados/sangue , Ácidos Graxos/análise , Ácidos Graxos/sangue , Ácidos Graxos/metabolismo , Peroxidação de Lipídeos , Fígado/química , Ratos Wistar
2.
Braz. j. med. biol. res ; 31(8): 1075-9, Aug. 1998.
Artigo em Inglês | LILACS | ID: lil-216827

RESUMO

Spirulina maxima, which is used as a food additive, is a microalga rich in protein and other essential nutrients. Spirullina contains phenolic acids, tocopherols and Beta-carotene which are known to exhibit antioxidant properties. The aim of the present study was to evaluate the antioxidant capacity of a Spirulina extract. The antioxidant activity of a methanolic extract of Spirulina was determined in vitro and in vivo. The in vitro antioxidant capacity was tested on a brain homogenate incubated with and without the extract at 37 degrees Celsius. The IC(50) (concentration which causes a 50 per cent reduction of oxidation) of the extract in this system was 0.18 mg/ml. The in vivo antioxidant capacity was evaluated in plasma and liver of animals recceiving a daily dose of 5 mg for 2 and 7 weeks Plasma antioxidant capacity was measured in brain homogenate incubated for 1 h at 37 degrees Celsius. The production of oxidized compounds in liver after 2 h of incubation at 37 degrees Celsius was measured in terms of thiobarbituric acid reactant substances (TBARS) in control and experimental groups. Upon treatment, the antioxidant capacity of plasma was 71 per cent for the experimental group and 54 per cent for the control group. Data from liver spontaneous peroxidation studies were not significantly different between groups. The amounts of phenolic acids, alpha-tocopherol and Beta-carotene were determined in Spirulina extracts. The results obtained indicate that Spirulina provides some antioxidant protection for both in vitro and in vitro and vivo systems.


Assuntos
Animais , Masculino , Ratos , Antioxidantes/farmacologia , Eucariotos/química , Peroxidação de Lipídeos/efeitos dos fármacos , Antioxidantes/análise , beta Caroteno/análise , beta Caroteno/farmacologia , Encéfalo/efeitos dos fármacos , Sinergismo Farmacológico , Fígado/efeitos dos fármacos , Plasma/efeitos dos fármacos , Ratos Wistar , Vitamina E/análise , Vitamina E/farmacologia
3.
Arch. latinoam. nutr ; 34(3): 488-99, sept. 1984.
Artigo em Português | LILACS | ID: lil-24459

RESUMO

Os autores estudaram, em ratos, o efeito da ingestao das lectinas isoladas dos feijoes (Phaseolus vulgaris, L.) das variedades Jalo e Rico 23. Diferentes quantidades de lectinas foram adicionadas a dietas experimentais, variando-se a quantidade de proteinas de 5% ate 20%. A adicao de 1% das lectinas do feijao Jalo provocou diminuicao no crescimento dos ratos, alterou a glicemia serica e, tambem, reduziu a atividade da maltase e da invertase da mucosa intestinal. Efeitos semelhantes foram verificados com 5% de lectinas obtidas do feijao Rico 23. Concentracoes elevadas de proteinas na racao (20%) parece compensar eventuais alteracoes metabolicas


Assuntos
Animais , Ratos , alfa-Glucosidases , Fabaceae , Glicosídeo Hidrolases , Mucosa Intestinal , Fito-Hemaglutininas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA